EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA)

Katsumi Miyauchi iD, Hiroshi Iwata, Yuji Nishizaki iD, Teruo Inoue, Atsushi Hirayama, Kazuo Kimura iD, Yukio Ozaki iD, Toyoaki Murohara iD, Kenji Ueshima, Yoshihiro Kuwabara, Sachiko Tanaka-Mizuno iD, Naotake Yanagisawa iD und 3 weitere

Circulation · 2024

DOI: 10.1161/circulationaha.123.065520 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, 2024. Verfasst von Katsumi Miyauchi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan (K.M., H.I., Y.N., H.D.). Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary Artery Disease, Secondary Prevention. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Low plasma levels of eicosapentaenoic acid (EPA) are associated with cardiovascular events. This trial aimed to assess the clinical benefits of icosapent ethyl in patients with coronary artery disease, a low EPA/arachidonic acid (AA) ratio, and statin treatment. METHODS: In this prospective, multicenter, randomized, open-label, blinded end-point study, patients with stable coronary artery disease and a low EPA/AA ratio (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eicosapentaenoic AcidHydroxymethylglutaryl-CoA Reductase InhibitorsCoronary Artery DiseaseSecondary PreventionHumansMaleFemaleAgedMiddle AgedProspective StudiesDrug Therapy, CombinationTreatment OutcomeJapan

Stichwörter der Autor:innen

coronary artery diseaseeicosapentaenoic acidoutcome assessment, health care

Substanzen

Eicosapentaenoic AcidHydroxymethylglutaryl-CoA Reductase Inhibitorseicosapentaenoic acid ethyl ester

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan (K.M., H.I., Y.N., H.D.).
  • Japan Red Cross Society, Nasu Red Cross Hospital, Otawara, Tochigi, Japan (T.I.).
  • Dokkyo Medical University, Mibu, Tochigi, Japan (T.I.).
  • Osaka Anti-Tuberculosis Association, Osaka Fukujyuji Hospital, Neyagawa, Osaka, Japan (A.H.).
  • Department of Cardiology, Yokohama City University Medical Center, Kanagawa, Japan (K.K.).
  • Department of Cardiology, Fujita Health University, Toyoake, Aichi, Japan (Y.O.).

ORCID-Profile: Katsumi Miyauchi, Yuji Nishizaki, Kazuo Kimura, Yukio Ozaki, Toyoaki Murohara, Sachiko Tanaka-Mizuno, Naotake Yanagisawa, Tosiya Sato, Hiroyuki Daida

Zitieren

APA

Miyauchi, K., Iwata, H., Nishizaki, Y., Inoue, T., Hirayama, A., Kimura, K., Ozaki, Y., Murohara, T., Ueshima, K., Kuwabara, Y., Tanaka-Mizuno, S., Yanagisawa, N., Sato, T., Daida, H., & RESPECT-EPA Investigators (2024). Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation. https://doi.org/10.1161/circulationaha.123.065520

Vancouver

Miyauchi K, Iwata H, Nishizaki Y, Inoue T, Hirayama A, Kimura K, et al. Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA). Circulation. 2024. doi:10.1161/circulationaha.123.065520

BibTeX
@article{Miyauchi2024,
  author = {Miyauchi, Katsumi and Iwata, Hiroshi and Nishizaki, Yuji and Inoue, Teruo and Hirayama, Atsushi and Kimura, Kazuo and Ozaki, Yukio and Murohara, Toyoaki and Ueshima, Kenji and Kuwabara, Yoshihiro and Tanaka-Mizuno, Sachiko and Yanagisawa, Naotake and Sato, Tosiya and Daida, Hiroyuki and RESPECT-EPA Investigators, RESPECT-EPA Investigators},
  title = {Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA)},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.065520}
}
Kostenlos starten →